Cargando…
Synuclein gamma predicts poor clinical outcome in colon cancer with normal levels of carcinoembryonic antigen
BACKGROUND: Synuclein gamma (SNCG), initially identified as a breast cancer specific gene, is aberrantly expressed in many different malignant tumors but rarely expressed in matched nonneoplastic adjacent tissues. In this study, we investigated the prognostic potential of SNCG in colon cancer partic...
Autores principales: | Liu, Caiyun, Dong, Bin, Lu, Aiping, Qu, Like, Xing, Xiaofang, Meng, Lin, Wu, Jian, Eric Shi, Y, Shou, Chengchao |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2912867/ https://www.ncbi.nlm.nih.gov/pubmed/20604972 http://dx.doi.org/10.1186/1471-2407-10-359 |
Ejemplares similares
-
Extracellular gamma-synuclein promotes tumor cell motility by activating β1 integrin-focal adhesion kinase signaling pathway and increasing matrix metalloproteinase-24, -2 protein secretion
por: Liu, Caiyun, et al.
Publicado: (2018) -
Urine gamma-synuclein as a biomarker for the diagnosis of bladder cancer
por: Liu, Caiyun, et al.
Publicado: (2016) -
PRL-3 promotes cell adhesion by interacting with JAM2 in colon cancer
por: Lian, Shenyi, et al.
Publicado: (2016) -
Overexpression of synuclein-γ predicts lack of benefit from radiotherapy for breast cancer patients
por: Min, Li, et al.
Publicado: (2016) -
DIFFERENTIAL EXPRESSION OF CARCINOEMBRYONIC ANTIGEN AND NONSPECIFIC CROSSREACTING ANTIGEN GENES IN HUMAN COLON ADENOCARCINOMAS AND NORMAL COLON MUCOSA
por: Sato, Chieko, et al.
Publicado: (1988)